AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2020

Mar 9, 2020

30198_dirs_2020-03-09_c8b01a84-decf-42fc-a01e-5c4cca82574d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2020-03-05

Reporting Person: Pacelli Steven Robert (EVP Strategy and Corporate Dev)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-03-05	Common Stock	M	8927	$9.8	Acquired	83551	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-03-05	Incentive Stock Option (right to buy)	$9.8	M	8927	Disposed	2020-03-12	Common Stock (8927)	Direct

Footnotes

F1: Included in this number are 38,823 unvested restricted stock units, 14,987 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 19,251 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 4,585 of which were granted on March 8, 2017 and shall vest through March 8, 2020.